Exploring the binding capacity of lactic acid bacteria derived bacteriocins against RBD of SARS-CoV-2 Omicron variant by molecular simulations

Keyphrases

• Angiotensin-converting Enzyme 2 (ACE2) 14%
• Bacteriocin 100%
• Binding Capability 14%
• Binding Capacity 100%
• Binding Energy 14%
• Biosynthesized 14%
• COVID-19 Treatment 14%
• Enterocin A 28%
• Food Utilization 14%
• Food-grade 28%
• Haddock 28%
• High Transmission Rate 14%
• Infectiousness 14%
• Key Amino Acid Residues 14%
• Lactic Acid Bacteria 100%
• Lactococcin 14%
• Molecular Dynamics Simulation 28%
• Molecular Simulation 100%
• Omicron Variant 100%
• Pediocin 28%
• Peptide-based Therapeutics 14%
• Plantaricin EF 14%
• Potential Utilization 14%
• Protein-peptide Complexes 14%
• PyMOL 14%
• Receptor-binding Domain 100%
• Salivaricin 28%
• SARS-CoV-2 Genome 14%
• SARS-CoV-2 Omicron 100%
• Spike Protein 14%
• Spike Receptor Binding Domain 14%
• Therapeutic Candidates 14%
• Variants of Concern 14%
• Virus Binding 14%
• VOCs 14%
• Web Server 28%

Biochemistry, Genetics and Molecular Biology

• Bacteriocin 25%
• Binding Domain 100%
• Binding Energy 25%
• Computer Simulation 50%
• Lactic Acid Bacterium 100%
• Lantibiotic 100%
• Receptor Binding 100%
• SARS Coronavirus 100%
• Spike 50%
• Virus Attachment 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Amino Acid 25%
• Bacteriocin 25%
• Lactic Acid Bacterium 100%
• Lactococcin 25%
• Lantibiotic 100%
• Pediocin 50%
• Receptor 100%
• Receptor Protein 25%
• SARS Coronavirus 100%